| Literature DB >> 32070876 |
Xufeng Tao1, Qing Chen1, Ning Li1, Hong Xiang2, Yue Pan1, Yueyang Qu1, Dong Shang2, Vay Liang W Go3, Jing Xue4, Yongwei Sun4, Zhigang Zhang5, Junchao Guo6, Gary Guishan Xiao7.
Abstract
The underlying molecular mechanisms of chronic pancreatitis (CP) developing into pancreatic ductal adenocarcinoma (PDAC) remain largely unknown. Here we show that the level of serotonin in mouse pancreatic tissues is upregulated in caerulein-induced CP mice. In vitro study demonstrates that serotonin promotes the formation of acinar-to-ductal metaplasia (ADM) and the activation of pancreatic stellate cells (PSCs), which results from the activation of RhoA/ROCK signaling cascade. Activation of this signaling cascade increases NF-κB nuclear translocation and α-SMA expression, which further enhance the inflammatory responses and fibrosis in pancreatic tissues. Intriguingly, quercetin inhibits both ADM lesion and PSCs activation in vitro and in vivo via its inhibitory effect on serotonin release. Our findings underscore the instrumental role of serotonin-mediated activation of RhoA/ROCK signaling pathway in development of PDAC from CP and highlight a potential to impede PDAC development by disrupting tumor-promoting functions of serotonin.Entities:
Keywords: Acinar-to-ductal metaplasia; Chronic pancreatitis; PDAC; PSCs; Serotonin
Mesh:
Substances:
Year: 2020 PMID: 32070876 DOI: 10.1016/j.biopha.2020.109999
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529